Chemoinformaics analysis of Dihydrofurospongin-2
| Molecular Weight | 328.452 | nRot | 11 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 12 |
| Exact Molecular Weight | 328.204 | nRing | 2 |
| Solubility: LogS | -5.207 | nHRing | 2 |
| Solubility: LogP | 4.854 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 56.1462 |
| nHD | 0 | BPOL | 32.4298 |
| QED | 0.492 |
| Synth | 3.432 |
| Natural Product Likeliness | 1.415 |
| NR-PPAR-gamma | 0.648 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.033 |
| HIA | 0.014 |
| CACO-2 | -4.644 |
| MDCK | 0.0000201 |
| BBB | 0.051 |
| PPB | 0.950734 |
| VDSS | 2.548 |
| FU | 0.00846759 |
| CYP1A2-inh | 0.917 |
| CYP1A2-sub | 0.475 |
| CYP2c19-inh | 0.904 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.924 |
| CYP2c9-sub | 0.177 |
| CYP2d6-inh | 0.734 |
| CYP2d6-sub | 0.665 |
| CYP3a4-inh | 0.618 |
| CYP3a4-sub | 0.254 |
| CL | 11.545 |
| T12 | 0.794 |
| hERG | 0.051 |
| Ames | 0.008 |
| ROA | 0.915 |
| SkinSen | 0.38 |
| Carcinogencity | 0.857 |
| EI | 0.411 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.598743 |